Skip to main content
    H

    Hinge Health, Inc. (HNGE)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NYSE

    $115.71
    -0.27 (-0.23%)

    Market Cap: $9.36B

    Last updated: Nov 06, 2026 at 4:36 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    100%(6/6)
    Avg Surprise
    +169.93%
    Streak
    6 Q

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$0.79
    Range$0.63 - $1.78
    14 analysts
    Revenue Consensus
    $262M
    Range$258M - $278M
    16 analysts
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$0.79$0.63 - $1.78--14--
    Sep 26
    Reported Nov 2
    		$0.53$0.27$0.23 - $0.36+96.30%Beat13
    0
    1
    30d
    		+20.5%
    Jun 26
    Reported Aug 4
    		$0.66$0.28$0.16 - $0.36+135.71%Beat13
    4
    0
    30d
    		-5.7%
    Mar 26
    Reported May 5
    		$0.45$0.40$0.33 - $0.43+12.50%Beat10
    7
    1
    30d
    		+120.2%
    Dec 25
    Reported Feb 10
    		$0.49$0.43-+13.95%Beat13
    No revisions (30d)
    		-
    Sep 25
    Reported Nov 4
    		$0.44$0.24$0.22 - $0.26+83.33%Beat12
    No revisions (30d)
    		-
    Jun 25
    Reported Aug 5
    		$0.70$0.09$0.06 - $0.15+677.78%Beat12
    No revisions (30d)
    		-
    Mar 25
    Reported May 5
    		$0.20N/A-N/ABeat---

    Key Metrics

    Valuation
    P/E Ratio54.32EV/EBITDA50.48x
    Price/FCF32.18xFCF Yield3.11%
    Profitability
    Profit Margin21.00%Operating Margin22.50%
    ROE47.60%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio1.34xQuick Ratio1.30x
    Trading Statistics
    BetaN/AAvg Volume1.98M
    52-Week High$124.9452-Week Low$30.08

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$115.70
    SMA 20$111.05
    SMA 50$100.83
    SMA 200$68.92
    EMA 10$115.02
    EMA 20$111.27
    EMA 50$102.54
    EMA 200$77.59

    MACD

    Line: 5.05Signal: 5.03Hist: 0.02

    ADX

    ADX: 32.0+DI: 24.6-DI: 14.8

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down8.0
    PSAR$124.94

    Bollinger Bands

    Upper Band$122.48
    Lower Band$99.62
    %B Position2059%(Upper)
    Band Width0.70

    RSI (14-Day)

    Neutral
    62.5

    Momentum Oscillators

    Stoch %K68.9
    Stoch %D78.5
    Williams %R-42.7
    ROC (10d)3.8%
    Momentum4.19
    CCI (20d)61.9
    MFI (14d)71.9

    Volatility Measures

    ATR (14d)$5.24(4.5%)
    StdDev (20d)5.72
    Hist Vol41.1%(High)

    Volume Flow

    VWAP$115.14
    OBV98.0M
    AD Line36.1M
    CMF (20d)0.288

    Volume Metrics

    Avg Vol (20d)2.0M
    Vol Ratio0.6x
    VWMA (20d)$111.72

    Pivot Points

    R3$127.45
    R2$124.73
    R1$120.35
    Pivot Point$117.63
    S1$113.25
    S2$110.53
    S3$106.15

    Advanced Oscillators

    TSI36.03
    Ultimate Osc55.7
    KST181.96

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$212.82M$182.31M$170.73M$154.21M$139.10M$123.83M$117.26M$100.61M$89.83M$82.71M$81.52M$81.35M
    Cost of Revenue$28.87M$28.07M$26.55M$28.01M$41.34M$23.59M$21.17M$21.36M$23.21M$24.77M$23.05M$23.24M
    Gross Profit$183.95M$154.23M$144.17M$126.20M$97.76M$100.23M$96.09M$79.26M$66.62M$57.94M$58.47M$58.12M
    Operating Expenses$143.51M$122.16M$116.92M$132.29M$678.43M$87.10M$75.18M$83.10M$84.17M$89.36M$88.96M$80.43M
    R&D$34.06M$30.34M$32.76M$31.92M$279.96M$23.50M$22.37M$23.79M$24.92M$30.76M$28.58M$28.46M
    SG&A$28.04M$23.02M$24.37M$36.85M$251.24M$16.88M$16.81M$14.75M$14.35M$17.46M$0$0
    Operating Income$40.44M$32.07M$27.26M$-6,093,000$-580,671,000$13.14M$20.91M$-3,845,000$-17,551,000$-31,424,000$-30,488,000$-22,312,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$44.43M$35.94M$32.22M$-1,638,000$-575,977,000$18.14M$26.16M$1.45M$-12,565,000$-26,306,000$-24,550,000$-16,735,000
    Income Tax Expense$740,000$814,000$122,000$206,000$-326,000$998,000$951,000$1.11M$361,000$158,000$-437,000$32,000
    Net Income$43.69M$35.13M$32.09M$-1,844,000$-575,651,000$17.14M$27.12M$341,000$-12,926,000$-26,464,000$-24,113,000$-16,767,000
    EBITDA$61.16M$49.58M$29.69M$12.24M$-568,371,000$28.68M$22.69M$10.42M$-12,565,000$-30,810,000$-24,455,000$-16,641,000
    EBIT$40.44M$32.07M$28.47M$-1,638,000$-580,671,000$18.14M$21.32M$1.45M$-12,565,000$-31,424,000$-24,550,000$-16,735,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about HNGE

    News

    After relinquishing shares for taxes, Hinge Health (HNGE) president holds 665,247 shares.

    Hinge Health, Inc. President James Pursley relinquished 831 shares of Class A Common Stock on November 1, 2026...

    Stock Titan•11/3/26•Neutral

    After relinquishing shares for taxes, Hinge Health (HNGE) CFO holds 292,114 shares.

    Hinge Health's CFO, James Budge, relinquished 4,614 Class A common shares on November 1, 2026, at $114.32 per share. This transaction was to cover federal and state tax withholding obligations stemming from restricted...

    Stock Titan•11/3/26•Neutral

    A 10% stockholder proposes selling Hinge Health (NYSE: HNGE) shares through Raymond James.

    Insight Venture Partners X, L.P., a 10% stockholder in Hinge Health, Inc. (NYSE: HNGE), has proposed selling 749,091 Class A shares through Raymond James & Associates Inc. The aggregate market value of this proposed sale...

    Stock Titan•10/15/26•Neutral

    Insight Venture Partners X (Co-Investors) Files Form 144 for Proposed Sale of 17,825 Hinge Health Shares

    Insight Venture Partners X (Co-Investors), a 10% shareholder in Hinge Health, Inc. (NYSE:HNGE), has filed a Form 144 to sell 17,825 Class A shares...

    Kalkine Media•10/15/26•Somewhat-Bearish

    Hinge Health exec. chairman Gabriel Mecklenburg sells $20.6m in stock

    Hinge Health's Executive Chairman and Co-Founder, Gabriel M.I. Mecklenburg, sold over $20.6 million worth of Class A Common Stock on October 12, 2026, through a pre-arranged trading plan. Concurrently...

    Investing.com•10/14/26•Neutral

    HNGE Valuation and Fair Value

    P/E
    54.3x
    Forward P/E
    43.3x
    EV/EBITDA
    50.5x
    P/FCF
    32.2x
    P/B
    26.5x
    See GNG's fair value

    HNGE Profitability: Margins, ROIC and FCF

    Gross margin
    84.5%
    Operating margin
    22.5%
    Net margin
    21.0%
    ROE
    47.6%
    FCF yield
    3.1%

    HNGE Competitors

    CompanyTicker
    Henry Schein IncHSIC
    Madrigal Pharmaceuticals IncMDGL
    Vaxcyte IncPCVX
    Protagonist Therapeutics IncPTGX
    Nuvalent IncNUVL
    Krystal Biotech IncKRYS
    Bio-Rad Laboratories IncBIO
    Spyre Therapeutics Inc.SYRE

    Sector: Healthcare

    HNGE Analyst Ratings

    Consensus
    Buy
    Analysts
    17
    Strong Buy
    7
    Buy
    9
    Hold
    1
    Sell
    0
    Strong Sell
    0

    HNGE Bull Case vs Bear Case

    Bull case

    • HNGE has a 21.0% net profit margin.
    • HNGE beat EPS estimates in 100.0% of its last 6 reported quarters.
    • HNGE grew quarterly revenue 52.4% year over year.

    Bear case

    • HNGE trades at 54.3x trailing earnings.

    HNGE Earnings: Beat Rate and Next Report

    Beat rate
    6 of 6 quarters (100.0%)
    Average surprise
    169.9%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $0.79

    HNGE Earnings Call

    The latest HNGE earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    HNGE ETF Holders

    GNG tracks 9 ETFs that hold HNGE. The largest weights:

    1. Fidelity Enhanced Small Cap Core ETF (FESM), 0.32% of the fund
    2. Vanguard Morningstar Small-Cap Growth ETF (VBK), 0.08% of the fund
    3. Vanguard Morningstar Small-Cap Value ETF (VBR), 0.06% of the fund
    4. Vanguard Health Care Index Fund ETF Shares (VHT), 0.06% of the fund
    5. Royce Value Trust Inc (RVT), 0.06% of the fund
    Open the ETF Stock Exposure tool for HNGE

    Frequently Asked Questions About HNGE

    Does HNGE pay dividends?

    Hinge Health, Inc. (HNGE) does not currently pay a regular dividend.

    What is HNGE's P/E ratio?

    Hinge Health, Inc. has a price-to-earnings (P/E) ratio of 54.32.

    What is HNGE's market cap?

    Hinge Health, Inc. (HNGE) has a market capitalization of $9.36B with a current stock price of $115.71.

    Related stocks

    Sector: Healthcare

    All stocks starting with H

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In